A Bone Drug Prevents Breast Cancer’s Return

A drug called Zometa significantly reduces the risk that breast cancer will return in certain patients, researchers said this morning.
The Novartis drug is approved to treat the bones of cancer patients, but hasn’t previously been shown to reduce the risk of cancer recurrence. The study was presented at the American Society of Clinical Oncology conference. [...]